Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
375 News Items found
Finding
Three sets of PET images
DeepPET Uses Artificial Intelligence to Generate Images of the Body’s Internal Activities

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.
MSK President Craig Thompson
New Collaboration Will Accelerate US-China Clinical Trials

In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.
Science Byte
Ribbon diagram of an anthrax protein.
Scientists Discover Keys to Immune Response against Anthrax

Researchers clarify how the immune system activates an inflammatory defense against pathogens.
In the Lab
In this fluorescent microscopy image of endoderm tissue from a mouse embryo, cell membranes are red, cell nuclei are blue, and extra-embryonic endoderm cells are green (they appear turquoise because blue and green are merged).
Scientists Rewrite the Textbook of Organ Development, One Cell at a Time

A large study that analyzed nearly 120,000 cells in a developing mouse embryo is full of surprises.
Feature
Model of TGF-beta molecule
An Old Protein Gets a New Look: Researchers Target TGF-ß to Make Immunotherapy More Effective

Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.
In the News
an illustration of cancer metastasis
AACR 2019 Research Roundup: Nanosensors for Cancer, New Immunotherapy Targets, a Road Map of Metastasis, and CAR T Fratricide

Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.
In the Clinic
MSK medical oncologist David Hyman
When a Cancer Therapy Stops Working: Experimental Drug Addresses Resistance

Results from the first phase I clinical trial of a new drug were presented at the American Association for Cancer Research’s meeting.
In the Clinic
Scientific Image
CAR Therapy for Solid Tumors Draws Attention at Annual Cancer Conference

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.
In the Lab
Microscopic image of cancer cells and C. elegans cells undergoing entosis.
A Death Wish That Allows Worms to Thrive — and What It Tells Us About Cancer Biology

Researchers discover that a curious type of cell death plays a role in normal development.
In the Lab
A cartoon depicting a cleaning crew
Cellular “Garbage Collectors” Are Key to Cancer’s Growth

A new study suggests a way to target cancer by interfering with its system of waste removal.